TORONTO, Feb. 2 /CNW/ - DELISTING REVIEW Angiotech Pharmaceuticals, Inc. (the "Company") - Further to TSX Bulletin 2011-0140 dated January 28,
2011, TSX has determined to delist the Common Shares (Symbol: ANP) of the Company at the close of market on March 3, 2011 for failure to
meet the continued listing requirements of TSX. The Common Shares will
remain suspended from trading.
About TMX Group
TMX Group's key subsidiaries operate cash and derivative markets for
multiple asset classes including equities, fixed income and energy.
Toronto Stock Exchange, TSX Venture Exchange, Montreal Exchange,
Natural Gas Exchange, Boston Options Exchange (BOX), Shorcan, Equicom
and other TMX Group companies provide trading markets, clearing
facilities, data products and other services to the global financial
community. TMX Group is headquartered in Toronto with offices in
Montreal, Calgary and Vancouver. For more information about TMX Group,
visit our website at www.tmx.com.
SOURCE TMX GROUP INC.
For further information:
Corporate Communications, TMX Group Inc., Toll Free 1-888-873-8392, email@example.com.